Objectives:
1. Describe the limitations of the current lymphoma classification scheme.
2. Review recent research purporting to identify genomic subclasses of B-cell lymphomas.
3. Summarize evidence base to date for targeted therapies in B-cell lymphomas.
Session date:
06/07/2018 - 12:00pm to 1:00pm CDT
Location:
NorthShore - Evanston
Evanston, IL
60201
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Michael Leukam, MD, MS